Eaton Vance Management’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-66	Closed	-$3K	–	1958
2021 Q4	$3K	Hold	66	–	–	﹤0.01%	2691
2021 Q3	$0	Hold	66	–	–	﹤0.01%	2116
2021 Q2	$2K	Buy	+66	New	+$2K	﹤0.01%	2704